{
    "root": "2f9eed08-35aa-d323-e063-6294a90a63a9",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Amoxicillin",
    "value": "20250305",
    "ingredients": [
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "AMOXICILLIN",
            "code": "804826J2HU"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3"
        }
    ],
    "indications": "Adults and Pediatric Patients\n                  \n                  \n                     \n                        Upper Respiratory Tract Infections of the Ear, Nose, and Throat\n                     \n                  \n                  Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of\n \n  Streptococcusspecies. (α- and β-hemolytic isolates only),\n \n  Streptococcus pneumoniae,\n \n  Staphylococcus spp., or\n \n  Haemophilus influenzae.\n                  \n                  \n                     \n                        Infections of the Genitourinary Tract\n                     \n                  \n                  Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of\n \n  Escherichia coli, Proteus mirabilis, or Enterococcus faecalis.\n                  \n                  \n                     \n                        Infections of the Skin and Skin Structure\n                     \n                  \n                  Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of\n \n  Streptococcus spp.(α- and β-hemolytic isolates only),\n \n  Staphylococcus spp., or E. coli.\n                  \n                  \n                     \n                        Infections of the Lower Respiratory Tract\n                     \n                  \n                  Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of\n \n  Streptococcus spp.(α- and β-hemolytic isolates only),\n \n  S. pneumoniae, Staphylococcus spp.,or\n \n  H. influenzae.\n                  \n                  \n                     Adult Patients Only\n                  \n                  \n                     \n                        \n                           Helicobacter pyloriInfection and Duodenal Ulcer Disease\n  \n   \n                     \n                  \n                  \n                     \n                        Triple therapy for Helicobacter pylori (H.pylori) with clarithromycin and lansoprazole\n                     \n                  \n                  Amoxicillin, in combination with clarithromycin plus lansoprazole as triple therapy, is indicated for the treatment of patients with\n \n  H. pyloriinfection and duodenal ulcer disease (active or 1-year history of a duodenal ulcer) to eradicate\n \n  H. pylori.Eradication of\n \n  H. pylorihas been shown to reduce the risk of duodenal ulcer recurrence.\n\n \n                  \n                     \n                        Dual therapy for H. pylori with lansoprazole\n                     \n                  \n                  Amoxicillin, in combination with lansoprazole delayed-release capsules as dual therapy, is indicated for the treatment of patients with\n \n  H. pyloriinfection and duodenal ulcer disease (active or 1-year history of a duodenal ulcer)\n \n  who are either allergic or intolerant to clarithromycin or in whom resistance to clarithromycin is known or suspected.(See the clarithromycin package insert, MICROBIOLOGY.) Eradication of\n \n  H. pylorihas been shown to reduce the risk of duodenal ulcer recurrence.\n\n \n                  \n                     Usage\n                  \n                  To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and other antibacterial drugs, amoxicillin should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.",
    "contraindications": "Click or tap here to enter text.",
    "warningsAndPrecautions": "Amoxicillin Capsules, USP, for oral administration, contain 250 mg amoxicillin as the trihydrate and are supplied as:\n                  250 mg: yellow, opaque, hard gelatin capsules imprinted AMOX 250 on one side and GG 848 on the other side.\n                  \n                  NDC: 70518-2188-00\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  \n                  Store capsules, tablets and unreconstituted powder for oral suspension at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature]. Dispense in a tight container.\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions": "Amoxicillin is contraindicated in patients who have experienced a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to amoxicillin or to other β-lactam antibacterial drugs (e.g., penicillins and cephalosporins)."
}